FDA also supports the removal of the HeartWare HVAD System from the market.
Nearly 32,000 stent systems have been recalled in the United States.
A product issue could cause keys to become unresponsive or stuck, leading to infusion delays.
Reported issues related to the device include two injuries and one death.
There have been 29 complaints, including 19 serious injuries and two deaths, related to the device issue.
All commercial, clinical, R&D and manufacturing activities surrounding the product will end.
A product issue could lead to serious health consequences, including loss of consciousness, bleeding, fluid buildup around the heart and death.
After prompting from the agency, Allergan issued a worldwide recall of its BIOCELL textured breast implants and tissue expanders.
A product malfunction could cause potential over-infusion or unintended delivery of medication.
The agency is recommending that patients replace their affected pumps with models that can better protect against the risks.